Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (IST:MEDTR)
17.79
-0.36 (-1.98%)
At close: Nov 18, 2026
IST:MEDTR Revenue
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi had revenue of 797.70M TRY in the quarter ending September 30, 2026, with 23.06% growth. This brings the company's total for the last twelve months to 2.80B, down -9.36% year-over-year. In the year 2025, Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi had annual revenue of 2.87B with 4.83% growth. That makes Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi the 27,261st largest company in the world by revenue and 355th in Turkey.
Revenue (ttm)
2.80B
Revenue Growth
-9.36%
P/S Ratio
0.76
Revenue / Employee
3.65M
Employees
761
Market Cap
2.12B
Revenue by Geography
- Foreign 1.80B 62.6%
- Turkey 1.07B 37.3%
- Unallocated 1.12M 0.0%
Fiscal year ended Dec 31, 2025 See the full IST:MEDTR breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.87B | 132.29M | 4.83% |
| Dec 31, 2024 | 2.74B | 644.58M | 30.74% |
| Dec 31, 2023 | 2.10B | 501.03M | 31.40% |
| Dec 31, 2022 | 1.60B | 1.22B | 324.48% |
| Dec 31, 2021 | 375.93M | 16.61M | 4.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.